| Literature DB >> 28475627 |
Daniel Valent1, Laura Arroyo1, Raquel Peña1,2, Kuai Yu1, Ricard Carreras3, Eva Mainau4, Antonio Velarde3, Anna Bassols1,2.
Abstract
Peripheral blood mononuclear cells (PBMC) are an interesting sample for searching for biomarkers with proteomic techniques because they are easy to obtain and do not contain highly abundant, potentially masking proteins. Two groups of pigs (n = 56) were subjected to mixing under farm conditions and afterwards subjected to different management treatments: negative handling (NH) and positive handling (PH). Serum and PBMC samples were collected at the beginning of the experiment one week after mixing (t0) and after two months of different handling (t2). Brain areas were collected after slaughter and neurotransmitters quantified by HPLC. Hair cortisol and serum acute phase proteins decreased and serum glutathione peroxidase increased at t2, indicating a lower degree of stress at t2 after adaptation to the farm. Differential gel electrophoresis (DIGE) was applied to study the effects of time and treatment on the PBMC proteome. A total of 54 differentially expressed proteins were identified, which were involved in immune system modulation, cell adhesion and motility, gene expression, splicing and translation, protein degradation and folding, oxidative stress and metabolism. Thirty-seven protein spots were up-regulated at t2 versus t0 whereas 27 were down-regulated. Many of the identified proteins share the characteristic of being potentially up or down-regulated by cortisol, indicating that changes in protein abundance between t0 and t2 are, at least in part, consequence of lower stress upon adaptation to the farm conditions after group mixing. Only slight changes in brain neurotransmitters and PBMC oxidative stress markers were observed. In conclusion, the variation in hair cortisol and serum APPs as well as the careful analysis of the identified proteins indicate that changes in protein composition in PBMC throughout time is mainly due to a decrease in the stress status of the individuals, following accommodation to the farm and the new group.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28475627 PMCID: PMC5419571 DOI: 10.1371/journal.pone.0176928
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Experimental timeline showing dates for animal handling, treatments and sample collection.
Cortisol, acute phase proteins and GPx in pigs subjected to PH and NH.
| t 0 | t 2 | Handling | Time | Handling*Time | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NH | PH | NH | PH | ||||||||
| Mean | SE | Mean | SE | Mean | SE | Mean | SE | ||||
| Hair Cortisol | 24.70 | 2.05 | 19.80 | 1.35 | 20.80 | 2.00 | 17.61 | 1.53 | 0.208 | 0.007 | 0.852 |
| Serum Cortisol | 23.50 | 2.22 | 17.57 | 1.77 | 24.21 | 2.09 | 21.20 | 2.09 | 0.094 | 0.252 | 0.410 |
| Saliva Cortisol | 3.47 | 0.30 | 4.25 | 0.57 | 3.57 | 0.21 | 3.60 | 0.27 | 0.604 | 0.172 | 0.826 |
| Haptoglobin | 0.64 | 0.07 | 0.86 | 0.07 | 0.39 | 0.06 | 0.43 | 0.04 | 0.166 | <0.0001 | 0.047 |
| CRP | 16.81 | 1.29 | 19.19 | 1.79 | 9.23 | 1.36 | 8.64 | 0.91 | 0.946 | <0.0001 | 0.218 |
| Pig-MAP | 0.98 | 0.10 | 1.00 | 0.10 | 0.80 | 0.08 | 0.92 | 0.12 | 0.764 | 0.021 | 0.588 |
| GPx | 6067 | 214 | 6149 | 188 | 7944 | 302 | 7841 | 246 | 0.975 | <0.0001 | 0.475 |
Fig 2Master gel from porcine PBMC.
The position of the differentially abundant spots that were identified is shown.
List of proteins differentially expressed in PBMC at t2 versus t0 in PH and NH groups.
Proteins with a Fold-change ≥ 1.5 and P < 0.05 in at least one of the comparisons are included. The ratio between NH t2/t0 and PH t2/t0 is shown to visualize which group shows the larger variation. ND: not determined if one of the groups does not comply with the criteria of Fold-change ≥ 1.5 and P < 0.05. NR: Not represented on STRING.
| NH | PH | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| t2/t0 | t2/t0 | ||||||||
| Spot | Identification UniProt Pig | Gene | Accession Number UniProt Pig | STRING Name | Fold | Fold | Fold-change Ratio NH/PH | ||
| Group A | |||||||||
| 861 | Annexin | ANXA1 | F1SJB5_PIG | ANXA1 | -4.1 | 0.004 | -2.8 | 0.0003 | 1.46 |
| Leukocyte elastase inhibitor | SERPINB1 | ILEU_PIG | SERPINB1 | ||||||
| 883 | Annexin | ANXA1 | F1SJB5_PIG | ANXA1 | -5.7 | 0.002 | -2.7 | 0.049 | 2.11 |
| 987 | EF-hand domain-containing protein D2 | EFHD2 | F1SUW3_PIG | EFHD2 | 1.8 | 0.042 | 2.1 | 0.026 | 0.86 |
| 1046 | High mobility group protein B1 | HMGB1 | F2Z594_PIG | HMGB1 | -2.2 | 0.002 | -2.4 | 0.018 | 0.92 |
| 1240 | Calcium-binding protein A9 | S100A9 | C3S7K6_PIG | S100A9 | -11.8 | 0.0007 | -4.3 | 0.025 | 2.74 |
| 1275 | Peptidyl-prolyl cis-trans isomerase A | PPIA | PPIA_PIG | PPIA | -2.1 | 0.046 | -1.7 | 0.036 | 1.24 |
| 1607 | High mobility group protein B1 | HMGB1 | F2Z594_PIG | HMGB1 | -1.9 | 0.006 | -2 | 0.014 | 0.95 |
| 1729 | Plastin-2 | LCP1 | F1RK02_PIG | LCP1 | -2.9 | 0.01 | -2 | 0.016 | 1.45 |
| Group B | |||||||||
| 183 | Integrin alpha-IIb | ITGA2B | F1RQY8_PIG | ITGA2B | 2.1 | 0.003 | 1.6 | 0.027 | 1.31 |
| 187 | Integrin alpha-IIb | ITGA2B | F1RQY8_PIG | ITGA2B | 2.6 | 0.017 | 1.7 | 0.024 | 1.53 |
| 265 | Filamin-A | FLNA | Q2YHQ3_PIG | FLNA | 4.2 | 0.0007 | 3.3 | 0.008 | 1.27 |
| 267 | Filamin-A | FLNA | Q2YHQ3_PIG | FLNA | 3.5 | 0.003 | 2.8 | 0.015 | 1.25 |
| 408 | Coronin 1 C | CORO1C | F1RGA9_PIG | CORO1C | 2.4 | 9.6E-05 | 4.3 | 0.022 | 0.56 |
| 511 | Fibrinogen Beta Chain | FGB | F1RX37_PIG | FGB | 3.9 | 0.007 | 2.1 | 0.041 | 1.86 |
| 528 | Fibrinogen Alpha Chain | FGA | F1RX36_PIG | FGA | 3 | 0.001 | 2 | 0.025 | 1.50 |
| 555 | Coronin 1 A | CORO1A | G8G223_PIG | CORO1A | -2 | 0.003 | -1.4 | 0.035 | ND |
| 556 | Fibrinogen beta chain | FGB | F1RX37_PIG | FGB | 3.9 | 0.012 | 1.9 | 0.044 | 2.05 |
| 594 | Coronin 1A | CORO1A | I3LR17_PIG | CORO1A | -2 | 0.047 | -1.4 | 0.032 | ND |
| 604 | Fibrinogen gamma chain | FGG | F1RX35_PIG | FGG | 3 | 0.001 | 2 | 0.046 | 1.50 |
| 613 | Integrin-linked protein kinase | ILK | I3L9C8_PIG | ILK | 4.5 | 0.01 | 2.6 | 0.025 | 1.73 |
| 620 | Testin | TES | TES_PIG | TES | 1.5 | 0.046 | 2.4 | 0.027 | 0.63 |
| 705 | Pleckstrin | PLEK | F1SJ07_PIG | PLEK | 2.6 | 0.005 | 2.1 | 0.019 | 1.24 |
| 725 | Pleckstrin | PLEK | F1SJ07_PIG | PLEK | 2.4 | 0.0005 | 2 | 0.042 | 1.20 |
| Alpha-centractin | ACTR1A | F2Z5G5_PIG | ACTR1A | ||||||
| 879 | PDZ and LIM domain protein 1 | PDLIM1 | T1RTP3_PIG | PDLIM1 | 1.5 | 0.009 | 2 | 0.048 | 0.75 |
| 893 | PDZ and LIM domain protein 1 | PDLIM1 | T1RTP3_PIG | PDLIM1 | 3.4 | 0.006 | 4.1 | 0.011 | 0.83 |
| 935 | Calponin-2 | CNN2 | CNN2_PIG | CNN2 | 2.2 | 0.008 | 1.7 | 0.019 | 1.29 |
| 961 | Calponin-2 | CNN2 | CNN2_PIG | CNN2 | -4.4 | 2.8E-05 | -3.8 | 0.007 | 1.16 |
| 968 | Tropomyosin alpha-1 chain | TPM1 | TPM1_PIG | TPM1 | 2.4 | 0.04 | 1.7 | 0.03 | 1.41 |
| 1201 | Myosin regulatory light polypeptide 9 | MYL9 | MYL9_PIG | MYL9 | 4 | 0.01 | 2.5 | 0.032 | 1.60 |
| 1202 | Myosin regulatory light chain 12B | MYL12B | F1SM78_PIG | MYL12B | 2.1 | 0.006 | 1.6 | 0.031 | 1.31 |
| 1399 | Filamin-A | FLNA | Q2YHQ3_PIG | FLNA | -2.6 | 0.011 | -1.7 | 0.022 | 1.53 |
| 1445 | Pleckstrin | PLEK | F1SJ07_PIG | PLEK | 5.7 | 0.0008 | 3.4 | 0.026 | 1.68 |
| 1457 | Fibrinogen beta chain | FGB | F1RX37_PIG | FGB | 3.5 | 0.0005 | 2.5 | 0.014 | 1.40 |
| 1580 | Fibrinogen beta chain | FGB | F1RX37_PIG | FGB | 3.1 | 0.001 | 2.2 | 0.042 | 1.41 |
| 1585 | Fibrinogen gamma chain | FGG | F1RX35_PIG | FGG | 3 | 0.007 | 1.8 | 0.02 | 1.67 |
| 1601 | Fibrinogen alpha chain | FGA | Q28936_PIG | FGA | 9.4 | 0.005 | 8 | 0.003 | 1.18 |
| 1611 | WD repeat-containing protein 1 | WDR1 | K9IVR7_PIG | WDR1 | 3.3 | 0.004 | 6.7 | 0.017 | 0.49 |
| 1612 | Fibrinogen alpha chain | FGA | F1RX36_PIG | FGA | 8.6 | 0.015 | 6.4 | 0.004 | 1.34 |
| 1621 | von Willebrand factor | VWF | F5XVC2_PIG | VWF | 4.1 | 0.016 | 2.2 | 0.021 | 1.86 |
| 1623 | Endoplasmin | HSP90B1 | ENPL_PIG | HSP90B1 | 2.7 | 0.018 | 2 | 0.004 | 1.35 |
| 1693 | Vinculin | VCL | VINC_PIG | VCL | 5 | 0.003 | 2.7 | 0.023 | 1.85 |
| 1718 | Coagulation factor XIII, A1 polypeptide | F13A1 | K7GQL2_PIG | NR | 2.6 | 0.009 | 1.6 | 0.047 | 1.63 |
| 1732 | Caldesmon | CALD1 | F1SNH3_PIG | CALD1 | 2.5 | 0.014 | 1.6 | 0.036 | 1.56 |
| 1785 | WD repeat-containing protein 1 | WDR1 | K9IVR7_PIG | WDR1 | 2.7 | 0.029 | 1.7 | 0.015 | 1.59 |
| Fibrinogen beta chain | FGB | F1RX37_PIG | FGB | ||||||
| Group C | |||||||||
| 353 | Far upstream element-binding protein 2 | KHSRP (FUBP2) | F1SBT6_PIG | KHSRP | -3.4 | 0.001 | -1.2 | 0.23 | ND |
| 561 | tRNA-splicing ligase RtcB homolog | RTCB | RTCB_PIG | C22orf28 | -2 | 0.003 | -1.4 | 0.018 | ND |
| 800 | Elongation factor 1-alpha | EEF1A1 | Q0PY11_PIG | EEF1A1 | -2.3 | 0.007 | -1.5 | 0.031 | 1.53 |
| 961 | Heterogeneous nuclear ribonucleoprotein A2/B1 | HNRNPA2B1 | M3UZ37_PIG | HNRNPA2B1 | -4.4 | 2.8E-05 | -3.8 | 0.007 | 1.16 |
| 968 | Heterogeneous nuclear ribonucleoprotein K | HNRNPK | I3LQS0_PIG | HNRNPK | 2.4 | 0.04 | 1.7 | 0.03 | 1.41 |
| 1117 | Heterogeneous nuclear ribonucleoprotein A2/B1 | HNRNPA2B1 | M3UZ37_PIG | HNRNPA2B1 | -5.6 | 0.044 | -2.9 | 0.014 | 1.93 |
| 1152 | Heterogeneous nuclear ribonucleoprotein A2/B1 | HNRNPA2B1 | M3UZ37_PIG | HNRNPA2B1 | -11.6 | 0.048 | -5.2 | 0.002 | 2.23 |
| 1281 | GTP-binding protein Rheb | RHEB | F2Z5R2_PIG | RHEB | -1.9 | 0.022 | -2.3 | 0.005 | 0.83 |
| 1347 | Histone H2B | HIST1H2BF | F2Z580_PIG | HIST1H2BF | -1.9 | 0.009 | -2.3 | 0.0002 | 0.83 |
| 1351 | Histone H2B | HIST1H2BF | F2Z580_PIG | HIST1H2BF | -1.8 | 0.014 | -2.6 | 0.006 | 0.69 |
| 1611 | Far upstream element-binding protein 1 | FUBP1 | F1S9S5_PIG | FUBP1 | 3.3 | 0.004 | 6.7 | 0.017 | 0.49 |
| 1674 | Histone H2B | HIST1H2BF | F2Z580_PIG | HIST1H2BF | -2.4 | 0.008 | -2.4 | 0.0001 | 1.00 |
| Group D | |||||||||
| 594 | Chaperonin containing TCP1, subunit 2 (Beta) | CCT2 | D0G0C8_PIG | CCT2 | -2 | 0.047 | -1.4 | 0.032 | ND |
| 1027 | Proteasome subunit alpha type-4 | PSMA4 | F2Z528_PIG | PSMA4 | 2.2 | 0.009 | 1.4 | 0.016 | ND |
| 1052 | Proteasome activator complex subunit 1 | PSME1 | PSME1_PIG | PSME1 | -2.2 | 0.0005 | -1.7 | 0.034 | 1.29 |
| 1275 | SUMO-conjugating enzyme UBC9 | UBE2I | I3LSZ1_PIG | UBE2I | -2.1 | 0.046 | -1.7 | 0.036 | 1.24 |
| 1700 | Proteasome activator complex subunit 2 | PSME2 | PSME2_PIG | PSME2 | -2.9 | 0.001 | -2.2 | 0.008 | 1.32 |
| Group E | |||||||||
| 594 | Cytosol aminopeptidase | LAP3 | I3LD43_PIG | LAP3 | -2 | 0.047 | -1.4 | 0.032 | ND |
| 1302 | Peroxiredoxin-5, mitochondrial | PRDX5 | F1RQP0_PIG | PRDX5 | -2.6 | 0.005 | -1.8 | 0.016 | 1.44 |
| 1686 | Cytosolic non-specific dipeptidase | CNDP2 | F1SNL7_PIG | CNDP2 | -2.3 | 0.003 | -2.3 | 0.008 | 1.00 |
| Group F | |||||||||
| 528 | GMP synthase | GMPS | I3LJ73_PIG | GMPS | 3 | 0.001 | 2 | 0.025 | 1.50 |
| 705 | Small calcium-binding mitochondrial carrier 1 | SLC25A24 | B2MUB6_PIG | SLC25A24 | 2.6 | 0.005 | 2.1 | 0.019 | 1.24 |
| 935 | Monoglyceride lipase | MGLL | B8XSJ9_PIG | MGLL | 2.2 | 0.008 | 1.7 | 0.019 | 1.29 |
| 951 | Malate dehydrogenase, cytoplasmic | MDH1 | MDHC_PIG | MDH1 | -2.3 | 0.002 | -1.6 | 0.031 | 1.44 |
| 1386 | Histidine triad nucleotide-binding protein 1 | HINT1 | F1RKI3_PIG | HINT1 | -2.8 | 0.011 | -1.9 | 0.026 | 1.47 |
| 1486 | Aconitate hydratase, mitochondrial | ACO2 | F1SRC5_PIG | ACO2 | -2 | 0.028 | -1.5 | 0.044 | 1.33 |
Fig 3Gene Ontology analysis of proteins identified by DIGE with fold change ≥1.5 and P<0.05 criteria, classified as molecular function and cellular component.
A) Global analysis of GO categories. Molecular function defined mainly binding proteins (40%) mostly related to protein-protein interaction, structural proteins involved in cell cytoskeleton (23%) and proteins with catalytic activity (28%), specifically hydrolase activity. Regarding cell component, cytoplasm (40%) and cytoskeleton (17%) were predominant. B) GO categories as displayed in NH and PH groups.
Fig 4Changes in protein abundance classified by their biological function.
Horizontal axes represent fold change (≥1.5 and P<0.05) in NH (blue) and PH (red) groups over time.
Fig 5STRING network of 54 proteins identified by DIGE.
Links between nodes represent different types of evidence for association (Yellow = Text mining, Pink = Experiments, Cian = Databases, Black = Coexpression, Green = Neighbourhood, Grey = Homology).
Fig 6Western blot of myosin light chain 2 (MYLC2) and fibrinogen (chains α, β, γ) from PBMCs from the individuals included in the DIGE study at t0 and t2 in NH and PH groups.
β-actin was used as loading control.
Fig 7Protein carbonylation (blue) and SOD activity (red) in PBMC extracts from the eight individuals included in the DIGE study.
The ratio between t2 and t0 is shown. Error bars correspond to the SE from three independent replicates for each assay.
Brain serotonin (5-HT) concentration (ng/g tissue) in the prefrontal cortex and amygdala of pigs subjected to PH or NH.
| Prefrontal cortex | 200.45 | 12.90 | 229.18 | 10.19 | 0.093 |
| Amygdala | 683.86 | 22.46 | 627.61 | 20.90 | 0.073 |
Fig 8Diagram showing the conclusions of the present work.
Changes in hair cortisol, serum acute phase proteins and GPx, and results of the proteomic analysis throughout the experimental 2-month period indicate that changes in PBMC proteins mainly reflect variations in the stress status of the pigs.